Related Experiment Video
Updated: Jun 14, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
S P Cole1, G Bhardwaj, J H Gerlach
1Cancer Research Laboratories, Queen's University, Kingston, Ontario, Canada.
Abstract:
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Insights
Lung cancer cells resistant to chemotherapy overexpress a novel ATP-binding cassette transporter. Gene amplification on chromosome 16 correlates with this overexpression and drug resistance, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Doxorubicin-selected H69AR lung cancer cells exhibit resistance to multiple chemotherapeutic agents.
- This resistance is not mediated by P-glycoprotein, a common multidrug resistance transporter.
- Understanding novel resistance mechanisms is crucial for developing effective lung cancer therapies.
Purpose of the Study:
- To identify and characterize novel genes and mechanisms conferring multidrug resistance in lung cancer.
- To investigate the genetic basis of drug resistance in the H69AR cell line.
Main Methods:
- Isolation of complementary DNA (cDNA) clones corresponding to overexpressed messenger RNAs (mRNAs) in H69AR cells.
- Analysis of mRNA expression levels using hybridization techniques.
- Gene amplification analysis via chromosomal mapping (chromosome 16, band p13.1).
- Correlation of gene amplification and mRNA expression with drug sensitivity.
Main Results:
- A novel mRNA (7.8–8.2 kilobases) was found to be 100- to 200-fold overexpressed in H69AR cells compared to parental H69 cells.
- This overexpression was linked to amplification of the cognate gene on chromosome 16 at band p13.1.
- Reversion to drug sensitivity correlated with decreased mRNA expression and loss of gene amplification.
- The identified mRNA encodes a member of the ATP-binding cassette (ABC) transmembrane transporter superfamily.
Conclusions:
- A novel ATP-binding cassette transporter, overexpressed due to gene amplification on chromosome 16, contributes to multidrug resistance in lung cancer.
- This finding provides a new molecular target for overcoming chemotherapy resistance in lung cancer.
Related Concept Videos
Cancer
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistant Cancers
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

